Table 1.
Demographics and baseline characteristics (intent-to-treat population)
| Sirolimus (n = 30) | Ciclosporin (n = 15) | |
|---|---|---|
| Recipient variables | ||
| Sex | ||
| Female n (%) | 14 (47) | 3 (20) |
| Male n (%) | 16 (53) | 12 (80) |
| Race | ||
| Caucasian n (%) | 25 (83) | 13 (87) |
| Hispanic n (%) | 3 (10) | 1 (7) |
| Asian n (%) | 1 (3) | 1 (7) |
| Other n (%) | 1 (3) | – |
| Age (years) median (range) | 49.0 (21–70) | 47.0 (28–64) |
| Weight (kg) median (range) | 78.2 (58.0–150.6) | 85.0 (41.8–125.0) |
| Primary reason for transplant | ||
| Cystic/polycystic kidney disease n (%) | 3 (10) | 6 (40) |
| Diabetes mellitus n (%) | 4 (13) | 2 (13) |
| Aetiology uncertain n (%) | 1 (3) | 2 (13) |
| Glomerulonephritis n (%) | 5 (17) | – |
| Hypertension n (%) | 6 (20) | 2 (13) |
| Pyelonephritis/interstitial nephritis n (%) | 2 (7) | – |
| Other n (%) | 9 (30) | 3 (20) |
| Donor variables | ||
| Age median (range) | 39.0 (8–59) | 42.0 (19–56) |
| Type of donor: | ||
| Deceased n (%) | 16 (53) | 7 (47) |
| Living related n (%) | 12 (40) | 7 (47) |
| Living unrelated n (%) | 2 (7) | 1 (7) |
| Other variables | ||
| Cold ischaemic time (h) | ||
| 0–30 n (%) | 28 (93) | 15 (100) |
| >30 n (%) | 2 (7) | – |